Skip to main navigation
  • T-Cell Therapy
    • Overview
    • TCRs for Solid Tumors
    • CAR-T Therapies
  • Controlled IL-12
  • Pipeline
  • Patients & Caregivers
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnerships
  • News & Publications
    • Press Releases
    • Scientific and Medical Publications
    • Videos
  • Investors

    Investor Relations

    • Investors Home
    • Press Releases
    • Stock Performance
    • SEC Filings
    • Events & Presentations
    • Quarterly Results
    • Corporate Governance
    • Analyst Coverage
    • Investor FAQs
    • Email Alerts
list Menu
  • Close Close
  • T-Cell Therapy
    • Overview
    • TCRs for Solid Tumors
    • CAR-T Therapies
  • Controlled IL-12
  • Pipeline
  • Patients & Caregivers
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnerships
  • News & Publications
    • Press Releases
    • Scientific and Medical Publications
    • Videos
  • Investors
    • Investors Home
    • Press Releases
    • Stock Performance
      • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
    • Financial Reports
    • SEC Filings
    • Events & Presentations
    • Corporate Governance
      • Medical Advisory Board
      • Board of Directors
      • Committees & Charters
    • Investor FAQ
    • Email Alerts

Ziopharm Oncology Fourth Quarter and Full Year 2020 Earnings Call

Feb 25, 2021
4:30 PM EST

Listen to Webcast

Supporting Materials

View Presentation 1.4 MB
  • Email Alerts Subscription
  • RSS News Feeds
  • Print
  • Share
>

  • Facebook
  • Google
  • LinkedIn
  • Twitter
  • RSS

© 2021 Ziopharm Oncology, Inc.

  • Privacy Policy
  • Terms and Conditions
  • Contact
  • Vimeo
  • Twitter